Home>
Stocks>
Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd (MANGALAM)

₹99.4▲0.45%

Get free price alerts. Set up your Free investment account to get Live Prices. >

Overview

Fundamentals

Q3 '23 Results

Technicals

News and Events

Mangalam Drugs and Organics Ltd share Performance

₹98.75
₹100.55
₹99.4
0.65%
Low
Day's Volatility:1.81%
High
1.16%
₹90.8
₹132.45
₹99.4
8.65%
Low
52 Weeks Volatility:41.90%
High
33.25%

Returns %
1 Month Return	-1 %
3 Month Return	-16.18 %
1 Year Return	-10.65 %

Market Stats
Previous Close	₹₹98.95
Open	₹₹99.45
Volume	₹10.17K
Upper Circuit	₹-
Lower Circuit	₹-
Market Cap	₹₹156.62Cr

Company Information

Mangalam Drugs and Organics Ltd is an India-based manufacturer of organic and inorganic chemicals, active pharma ingredients, API perfumery, disperse dye intermediates, bulk drugs, and bulk drug intermediates. Established in April 1972, the company has operations at Vapi in Gujarat and Sangamner in Maharashtra, and a Research and Development base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, dyes and intermediaries, Nimesulide, Amodiaquine Hydrochloride and Amodiaquine. The bulk drug production capacity of the Company was increased from 350 MTPA to 1260 MTPA between 2003-04 and 2009-10. In addition to this, the company developed and introduced two new bulk drugs: Bisoprolol Fumarate and Pantaprazole Sodium. Furthermore, an Intellectual Property Rights (IPR) and Regulatory Affairs Cell have been created for proper management and expansion of their products.

Share Price: ₹99.40 per share as on 16 May, 2024 04:01 PM
Market Capitalisation: ₹156.62Cr as of today
Revenue: ₹97.05Cr as on December 2023 (Q4 23)
Net Profit: ₹0.50Cr as on December 2023 (Q4 23)
Listing date: 23 May, 2005
Chairperson Name: Govardhan M Dhoot

Organisation	Mangalam Drugs and Organics Ltd
Headquarters
Industry	Pharmaceuticals
E-voting on shares	Click here to vote

Key events for Mangalam Drugs and Organics Ltd

Mangalam Global Q4 2024 Net Sales Up by 69.54% - 03 May, 2024
Mangalam Global Standalone March 2024 net sales increased by 69.54% YoY, with a quarterly net profit of Rs. 10.53 crore in March 2024, up 31.41% from the previous year. The company's EPS has also increased to Rs. 0.73 in March 2024. Mangalam Global shares closed at 23.55 on May 02, 2024 (NSE) and have given 53.42% returns over the last 6 months and -14.05% over the last 12 months.
Mangalam Worldwide Reports Strong Financial Results - 19 Apr, 2024
Mangalam Worldwide reports a 75.48% increase in net profit for Q4 2023 and a 26.77% increase in net profit for the full year ended March 2024, with sales also rising significantly.

Fundamentals of Mangalam Drugs and Organics Ltd

Insights on Mangalam Drugs and Organics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.10% to 0.26% in Mar 2024 quarter
NO EFFECT
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 93.2% return, outperforming this stock by 103.8%
NO EFFECT
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 122.3% return, outperforming this stock by 150.3%
NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.32% of holdings in Mar 2024 quarter
NEGATIVE IMPACT
Price Dip
In the last 3 years, MANGALAM stock has moved down by -28.0%
NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 49.58% to 49.42% in Mar 2024 quarter